Luis Alvarez is the Founder and Chief Executive Officer of Theradaptive and developed the concept for targeted regeneration platform during and following a combat tour in Iraq where several of his soldiers suffered severe extremity injuries.
Previously, Luis was the co-founding Deputy Director of the Department of Defense Regenerative Medicine Program and led the department’s largest recombinant biologics program through Phase II. Luis was a DARPA Service Chief Fellow and Academy Professor at the United States Military Academy, West Point.
Luis received his PhD in Biological Engineering from MIT where he was a Hertz Foundation Fellow.
